Letters, Testimony & Comments

August 18, 2006
The Biotechnology Industry Organization (BIO) appreciates this opportunity to testify before the Advisory Panel on Ambulatory Payment Classifications (the APC Panel). BIO is the largest trade organization to serve and represent the biotechnology...
August 9, 2006
BIO's comments on the CMS' Tracking Sheet regarding the development of a Clinical Research Policy (CRP) as a reconsideration of its national coverage decision (NCD) on Medicare coverage of clinical trials.
August 8, 2006
On August 1, 2006 the Centers for Medicare and Medicaid Services (CMS) released the fiscal year (FY) 2007 hospital inpatient prospective payment system (IPPS) final rule. /1 The rule will be published in Federal Register on Friday, August 18, and...
June 9, 2006
Dear Ambassador Schwab: The Russian Federation's accession to the World Trade Organization (WTO) would be an important step forward for global world trade. As you seek to conclude negotiations between the United States and the Russian...
May 12, 2006
Comments regarding the public notice of intent to initiate negotiations with Malaysia.
May 11, 2006
A bill to require the labeling of biotech fish and fish products.
April 11, 2006
A Panel from the BIO Annual Convention 2006.
April 6, 2006
Statement of Peter Young, President and CEO of AlphaVax, Inc. on Behalf of BIO, the Biotechnology Industry Organization Presented before the House Energy and Commerce Committee Subcommittee on Health April 6, 2006 Good afternoon and thank...
March 31, 2006
Letter to USTR on continuing concerns.
March 24, 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24, 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.